The FDA (Food & Drugs Administration) and U.S. Medicare and the UHMS (Medical Society of Hyperbaric and underwater medicine), approved the prescription of hyperbaric oxygen (and the insurance reinbursment) as a primary or complementary treatment to treat the following conditions:
- Tissue serious injury from burns, lacerations or trauma
- Necrotizing infections of soft tissues (soft tissue and bone)
- Carbon monoxide poisoning and organic solvents
- Wound healing problems
- Compromised grafts and flaps
- Arterial insufficiency ulcers
- Chronic refractory osteomyelitis
- Decompression sickness
- Radiation injuries
- Intracranial abscess
- Air embolism
- Clostridial myositis
- Gas gangrene
- Chronic anemia
HBO is also widely used as adjunctive therapy in those conditions or diseases in which physiological bases have been identified for use, as well as clinical evidence and / or experimental that might merit its use so that any disease in which there is a reduction oxygen supply, or inadequate or improper use, can potentially benefit from HBO.
The following is a summary of these conditions, compiled from the experiences and studies of institutions such as European and American Society of Hyperbaric Medicine, Committee for Hyperbaric Medicine Center (Spain) and the health sector in Colombia, Venezuela, Chile, Cuba, Mexico and Argentina